Biological tissue for surgical implantation

US9918832B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9918832-B2
Application numberUS-201113189036-A
CountryUS
Kind codeB2
Filing dateJul 22, 2011
Priority dateOct 27, 2006
Publication dateMar 20, 2018
Grant dateMar 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of treating a biological tissue that enables dry storage of said tissue is disclosed. In one embodiment, the method comprises contacting the biological tissue with a non-aqueous treatment solution comprising a polyhydric alcohol and a C 1 -C 3 alcohol and removing a portion of the treatment solution from the solution-treated biological tissue. Also disclosed is biological tissue prepared using the above process and prosthetic devices made with such tissue.

First claim

Opening claim text (preview).

We claim: 1. A sealed package containing a sterilized bioprosthesis comprising: a bioprosthetic heart valve comprising a pliable, elastic, and glutaraldehyde-fixed biological tissue having an interstitial volume comprising glycerol, wherein the biological tissue is coupled to a stent and wherein the bioprosthetic heart valve is treated with a solution comprising 50-90% glycerol and 50-10% ethanol; and the sealed package containing the bioprosthetic heart valve, wherein the sealed package does not contain a liquid storage solution in contact with the bioprosthetic heart valve. 2. The sealed package of claim 1 , wherein the biological tissue is selected from the group consisting of pericardium, aortic and pulmonary roots, tendons, ligaments, skin, facia, peritonium, pleura, and mitral and tricuspid valves. 3. The sealed package of claim 1 , wherein the biological tissue is decellularized. 4. The sealed package of claim 1 , wherein the stent is elastic and the bioprosthetic heart valve is collapsible. 5. The sealed package of claim 1 , wherein the sealed package is sterilized by a gas or by exposure to ionizing radiation. 6. The sealed package of claim 5 , wherein the gas is ethylene oxide.

Assignees

Inventors

Classifications

  • Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking · CPC title

  • characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents · CPC title

  • A61F2/2415Primary

    Manufacturing methods · CPC title

  • for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062) · CPC title

  • characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9918832B2 cover?
A method of treating a biological tissue that enables dry storage of said tissue is disclosed. In one embodiment, the method comprises contacting the biological tissue with a non-aqueous treatment solution comprising a polyhydric alcohol and a C 1 -C 3 alcohol and removing a portion of the treatment solution from the solution-treated biological tissue. Also disclosed is biological tissue prepa…
Who is the assignee on this patent?
Tian Bin, Davidson Jim, Edwards Lifesciences Corp
What technology area does this patent fall under?
Primary CPC classification A61F2/2415. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).